The IC 50 values for cisplatin of ovarian cancer (A2780), colon cancer (HCT8) and bladder cancer (T24) cell line pairs were determined after 5 days of continuous exposure to cisplatin using an MTT assay. The IC 50 value was estimated based on viability data of three independent experiments. Each cell line pair consists of a parental sensitive cell line and a resistant derivative (DDP). The difference in IC 50 value between sensitive and resistant cell lines is comparable to previously published data (Goto et al, 1995; Kool et al, 1997; Kotoh et al,1994; Schmidt and Chaney, 1993) B: A2780, HCT8 and T24 cells and their resistant counterparts were treated with 100 µM cisplatin for 2 hours after which total cellular platinum levels were determined using Atomic Absorption Spectrophotometry. Indicated is the average and standard deviation of three biological replicates. Note that reduced cellular platinum levels are found in the cisplatin resistant cell lines. Listed are all miRNAs that show a fold change ≥1.5 in the resistant cell line relative to its sensitive counterpart, as indicated by a red (expression is higher in the resistant cell line) or a green color (expression is lower in the resistant cell line). 
After 8 hours, the same cells were transfected with Renilla luciferase reporter constructs (psiCHECK™-2) containing 3'UTR regions of 500 bp surrounding the predicted miR-634 target sites of various target genes (Supplementary figure 7). ERK2 and RSK2 contain respectively three or two miR-634 binding sites, and for each site the 3'UTR region surrounding the target site was cloned. The Renilla luciferase activity was measured and normalized using the Firefly luciferase activity. The relative luciferase activity of cells transfected with the empty vector (EV) was set at 1. Depicted are the average values ± SD (n= 3). Spearman rank correlation tests were performed to assess the relation between miR-634 expression (miRNA dataset) and target gene expression (mRNA dataset). 
B:
Detection of RNU43 and RNU 48 by Taqman assay (ID # 001095 and ID # 001006, respectively). Both RNU43 and RNU48 expression was detected at the expected levels in both A2780, A2780-ddp and A2780-ddp transfected with a miR-634 mimic.
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